Clinical features, antibiotic susceptibility and treatment outcome of pediatric's Whitmore disease at Vietnam National Children’s Hospital

  • Lê Thị Yên Bệnh viện Nhi Trung ương
  • Nguyễn Văn Lâm Bệnh viện Nhi Trung ương
  • Hoàng Thị Bích Ngọc Bệnh viện Nhi Trung ương
  • Trần Minh Vương Bệnh viện Nhi Trung ương
  • Đào Hữu Nam Bệnh viện Nhi Trung ương
  • Nguyễn Sỹ Đức Đại học Y Hà nội

Main Article Content

Keywords

Whitmore, angle lymph node abscess, B. pseudomallei

Abstract

Whitmore's disease, also known as Melioidosis, is an infection in humans and animals caused by the bacterium Burkhoderia pseudomallei (B. pseudomallei). The disease can occur in all ages and regions throughout the country. Currently, in Vietnam, there are no adequate studies on the situation of Whitmore's disease in children. Objective: To describe the clinical characteristics, antibiotic sensitivity and treatment results of patient Whitmore. Subject and method: A retrospective study, describing case series, selecting all pediatric patients from 1 month to 15 years old diagnosed with Whitmore disease and treated at National Children's Hospital from 1/2016 to 01/2021. Result: 39 Whitmore children were treated at the National Children's Hospital for 5 years. In which, children ≤ 5 years old was 25 (64.1%), over 5 ≤ 10 years old was 11 (28.2%); over 10 years old was 3 (7.7%). Abscess of the angle of the jaw was the most common clinical manifestation (64.1%); followed by sepsis (20.5%); Dermatitis, meningitis, bronchitis and osteomyelitis. Specimens that were positive for B. pseudomallei were the most purulent abscesses in 24/29 patients. The sensitivity rate of bacteria to some commonly used antibiotics were ceftazidime (74%), imipenem (100%) and meropenem (100%), amoxicillin/clavulanic (65.7%), trimethoprim (54.5%). The number of patients who died was 5/39 (12.8%). Conclusion: Whitmore has a localized or generalized lesion, the most common clinical manifestation is an angle abscess, 100% is sensitive to meropennem, imipenem and only 74.2% is sensitive to ceftazidime.

Article Details

References

1. Currie B. (2015) Burkholderia pseudomallei and Burkholderia mallei: Melioidosis and glanders. In: Mandell G, Bennett J, Dolin R, eds. Principles and Practice of Infectious Diseases. Elsevier: 2541-2551.
2. Melioidosis Nature Reviews Disease Primers. Accessed July 19, 2023. https://www.nature.com/articles/nrdp2017107
3. Characterization of Ceftazidime Resistance Mechanisms in Clinical Isolates of Burkholderia pseudomallei from Australia | PLOS ONE. Accessed July19,2023.https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0030789
4. Quyết định 6101/QĐ-BYT 2019 Hướng dẫn chẩn đoán điều trị bệnh Whitmore. Accessed July 19, 2023. https://thuvienphapluat.vn/van-ban/The-thao-Y-te/Quyet-dinh-6101-QD-BYT-2019-Huong-dan-chan-doan-dieu-tri-benh-Whitmore-432635.aspx
5. Trinh TT, Hoang TS, Tran DA et al (2018) A simple laboratory algorithm for diagnosis of melioidosis in resource-constrained areas: a study from north-central Vietnam. Clin Microbiol Infect 24(1): 84.e1-84.e4. doi:10.1016/j.cmi.2017.07.029.
6. Phuong DM, Trung TT, Breitbach K et al (2008) Clinical and microbiological features of melioidosis in northern Vietnam. Trans R Soc Trop Med Hyg 102(1): 30-36. doi:10.1016/S0035-9203(08)70009-9.
7. Melioidosis in Southern Vietnam: clinical surveillance and environmental sampling - PubMed. Accessed July18,2023. https://pubmed.ncbi.nlm.nih.gov/10524986/.
8. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment - PubMed. Accessed July 19,2023. https://pubmed.ncbi.nlm. nih.gov/25643275/.
9. Lumbiganon P, Viengnondha S (1995). Clinical manifestations of melioidosis in children. Pediatr Infect DisJ 14(2): 136-140.doi:10.1097/00006454-199502000-00010.
10. Turner P, Kloprogge S, Miliya T et al (2016) A retrospective analysis of melioidosis in Cambodian children, 2009-2013. BMC Infectious Diseases;16. doi:10.1186/s12879-016-2034-9.
11. Nhung PH, Van VH, Anh NQ, Phuong DM (2019) Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam. Journal of Global Antimicrobial Resistance 18: 34-36. doi:10.1016/j.jgar.2019.01.024
12. Tan AL, Tan ML (2008) Melioidosis: antibiogram of cases in Singapore 1987-2007. Trans R Soc Trop Med Hyg 102 Suppl 1: 101-102. doi:10.1016/S0035-9203(08)70024-5.
13. Wuthiekanun V, Amornchai P, Saiprom N et al (2011) Survey of Antimicrobial Resistance in Clinical Burkholderia pseudomallei Isolates over Two Decades in Northeast Thailand . Antimicrob Agents Chemother 55(11): 5388-5391. doi:10.1128/AAC.05517-11.
14. Hassan MRA, Vijayalakshmi N, Pani SP et al (2014) Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia. Southeast Asian J Trop Med Public Health 45(3): 680-688.
15. McLeod C, Morris PS, Bauert PA et al (2015) Clinical presentation and medical management of melioidosis in children: A 24-year prospective study in the Northern Territory of Australia and review of the literature. Clin Infect Dis 60(1): 21-26. doi:10.1093/cid/ciu733.
16. Mohan A, Podin Y, Tai N, et al (2017) Pediatric melioidosis in Sarawak, Malaysia: Epidemiological, clinical and microbiological characteristics. PLoS NeglTropDis 11(6): 0005650. doi:10.1371/ journal.pntd.0005650.